The Reviews of the first session of the Open Class on AIPHARMS | The frontier ideas, progress and future of AI drug design
On the evening of June 22, 2022, the first session of the Open Class on AIPHARMS《Frontier Progress in AI Drug Design》, was launched online. Dr. David Xu, founder and CEO of AIxplorerbio, as a special host, delivered an opening speech and moderated the dis
2022.06.30